Quantcast

Quincy Bioscience Launches the Second E-Book of the Making Memories Series

July 31, 2014

Presenting the latest edition of the ‘Making Memories’ e-booklet series that provides tips for capturing memories of a new grandchild

Madison, WI (PRWEB) July 31, 2014

Quincy Bioscience, a fast-growing biotech company in Madison, Wis. and creators of brain health supplement Prevagen®, releases the second edition of the Making Memories e-booklet series – 10 Marvelous Tips for Making Memories: Birth of a Grandchild.

The Prevagen-sponsored e-book is a complimentary resource that offers exceptional memory-making tips and ideas for grandparents to utilize during the precious moments that follow the birth of a grandchild. Each concept published in the e-book is free or low-cost to create, yet holds rich significance.

Quincy Bioscience aims to support cognitive function and other normal health challenges such as mild memory loss associated with aging. The company executes that mission through the discovery, development and commercialization of novel technologies. Prevagen, the flagship consumer brand of Quincy Bioscience and leading brain health supplement, promotes preserving memories, while the Making Memories e-book series promotes creating memories.

All e-booklets are offered via online PDF. Learn more by clicking here.

About Quincy Bioscience:

Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/08/prweb12061169.htm


Source: prweb



comments powered by Disqus